...
首页> 外文期刊>The Permanente Journal >Association of Proteinuria with Central Venous Catheter Use at Initial Hemodialysis
【24h】

Association of Proteinuria with Central Venous Catheter Use at Initial Hemodialysis

机译:初始血液透析中蛋白尿与中央静脉导管使用的关联

获取原文
           

摘要

Context: Central venous catheter (CVC) use is associated with increased mortality and complications in hemodialysis recipients. Although prevalent CVC use has decreased, incident use remains high.Objective: To examine characteristics associated with CVC use at initial dialysis, specifically looking at proteinuria as a predictor of interest.Design: Retrospective cohort of 918 hemodialysis recipients from Kaiser Permanente Northwest who started hemodialysis from January 1, 2004, to January 1, 2014.Main Outcome Measures: Multivariable logistic regression was used to examine an association of proteinuria with the primary outcome of CVC use.Results: More than one-third (36%) of patients in our cohort started hemodialysis with an arteriovenous fistula, and 64% started with a CVC. Proteinuria was associated with starting hemodialysis with a CVC (likelihood ratio test, p 0.001) after adjustment for age, peripheral vascular disease, congestive heart failure, diabetes, sex, race, and length of predialysis care. However, on pairwise comparison, only patients with midgrade proteinuria (0.5-3.5??g) had lower odds of starting hemodialysis with a CVC (odds ratio = 0.39, 95% confidence interval = 0.24-0.65).Conclusion: Proteinuria was associated with use of CVC at initial hemodialysis. However, a graded association did not exist, and only patients with midgrade proteinuria had significantly lower odds of CVC use. Our findings suggest that proteinuria is an explanatory finding for CVC use but may not have pragmatic value for decision making. Patients with lower levels of proteinuria may have a higher risk of starting dialysis with a CVC.
机译:背景:中央静脉导管(CVC)的使用会增加血液透析患者的死亡率和并发症。尽管CVC的普遍使用已减少,但事件的使用率仍然很高目的:检查与初次透析时使用CVC相关的特征,特别是将蛋白尿作为研究对象的预测指标设计:回顾性队列研究了来自西北Kaiser Permanente的918名血液透析接受者从2004年1月1日至2014年1月1日。主要结果指标:多变量logistic回归用于检验蛋白尿与CVC使用的主要结局之间的关系。结果:本研究中超过三分之一(36%)的患者队列开始使用动静脉瘘进行血液透析,而64%的患者开始使用CVC。在调整了年龄,周围血管疾病,充血性心力衰竭,糖尿病,性别,种族和透析前护理时间之后,蛋白尿与通过CVC(似然比测试,p <0.001)开始血液透析有关。然而,在成对比较中,只有中度蛋白尿(0.5-3.5?g)患者开始进行CVC血液透析的几率较低(优势比= 0.39,95%置信区间= 0.24-0.65)。初次血液透析时使用CVC。但是,不存在分级关联,只有中度蛋白尿患者使用CVC的几率明显较低。我们的发现表明蛋白尿是CVC使用的一个解释性发现,但可能对决策没有实用价值。蛋白尿水平较低的患者开始CVC透析的风险可能更高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号